Pharmacy owner and wholesaler predicts earnings rise

Sigma Pharmaceuticals says it is on track to lift underlying earnings by at least 10% in the first half of its 2016/17 fiscal year.

The company also said at its annual general meeting on Wednesday that its full-year guidance for the current fiscal year remains unchanged.